Shares of Bodycote plc (LON:BOY - Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 580.58 ($7.80) and traded as high as GBX 596.50 ($8.01). Bodycote shares last traded at GBX 595 ($7.99), with a volume of 107,400 shares trading hands.
Analysts Set New Price Targets
Separately, Berenberg Bank reaffirmed a "buy" rating and issued a GBX 800 ($10.74) price target on shares of Bodycote in a research note on Monday, March 24th.
Check Out Our Latest Report on BOY
Bodycote Price Performance
The company has a debt-to-equity ratio of 20.84, a quick ratio of 0.74 and a current ratio of 0.81. The company has a 50-day moving average of GBX 570.59 and a 200-day moving average of GBX 580.34. The firm has a market capitalization of £1.08 billion, a price-to-earnings ratio of 18.08, a price-to-earnings-growth ratio of 1.44 and a beta of 1.18.
Bodycote (LON:BOY - Get Free Report) last released its quarterly earnings results on Tuesday, April 15th. The company reported GBX 48.60 ($0.65) earnings per share for the quarter. Bodycote had a return on equity of 8.14% and a net margin of 8.01%. As a group, research analysts anticipate that Bodycote plc will post 54.0540541 EPS for the current fiscal year.
Insider Activity at Bodycote
In other news, insider Ben Fidler sold 29,835 shares of the stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of GBX 465 ($6.24), for a total value of £138,732.75 ($186,293.47). Insiders own 2.32% of the company's stock.
About Bodycote
(
Get Free Report)
The leading provider of heat treatment and specialist thermal processing services worldwide.
Heat treatment encompasses a variety of techniques and specialist engineering processes which improve the properties of metals and alloys and extend the life of components and is a vital part of any manufacturing process.
Bodycote is uniquely placed via our global network and the experience and knowledge of our people to offer high quality, reliable and cost-effective services to manufacturers whatever their size or market sector.
Recommended Stories
Before you consider Bodycote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bodycote wasn't on the list.
While Bodycote currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
